Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
9 companies reporting in the next 90 days. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Monday, Oct 19 · in 53 days · 1 company | |||||
| SMMT | Summit Therapeutics Inc. | Oncology | $10.66B | +1.95% | |
| Tuesday, Oct 27 · in 61 days · 4 companies | |||||
| INCY | Incyte Corporation | Oncology | $26.29B | +9.13% | |
| 0J9P.L | Incyte Corporation | Oncology | $21.10B | +1.97% | |
| EXEL | Exelixis, Inc. | Oncology | $14.05B | +1.63% | |
| 0IJO.L | |||||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| Exelixis, Inc. |
| Oncology |
| $14.05B |
| +3.33% |
| Thursday, Oct 29 · in 63 days · 3 companies | |||||
| 6MK.DE | Merck & Co., Inc. | Oncology | $380.73B | +11.62% | |
| MRK | Merck & Co., Inc. | Oncology | $371.70B | +19.65% | |
| BMY | Bristol-Myers Squibb Company | Oncology | $138.74B | +8.57% | |
| Wednesday, Nov 4 · in 69 days · 1 company | |||||
| RVMD | Revolution Medicines, Inc. | Oncology | $45.35B | +12.39% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.